Warshaw H, Franz M, Powers M A, Wheeler M
Hope Warshaw Associates, Alexandria, Virginia 22308, USA.
Diabetes Care. 1996 Nov;19(11):1294-301. doi: 10.2337/diacare.19.11.1294.
The scientific literature demonstrates that fat replacers have a reasonable certainty of no harm. Whether they help produce desired health outcomes, i.e., decreased risk of coronary heart disease and certain types of cancer related to excess fat intake, weight reduction, changes in lipid profile, improved glycemic control, etc., depends on how individuals use these foods to change food choices and eating behaviors. As Miller and Rolls conclude, ...the use of fat-replaced foods alone should not be expected to produce spontaneous improvements in weight management. Such improvements will still be dependent on long-term behavioral changes that include not only modifications in fat, but also modifications in overall energy intake and increase in energy expenditure. (53) Though it has not been studied, one may conjecture that encouraging people with diabetes to use foods with fat replacers to achieve nutrition management goals requires sufficient education, continuous counseling, and an individual's conscientious commitment and readiness to change food habits.
科学文献表明，脂肪替代品不存在危害的合理确定性。它们是否有助于产生预期的健康结果，即降低冠心病风险以及与过量脂肪摄入相关的某些类型癌症的风险、减轻体重、改善血脂状况、改善血糖控制等，取决于个人如何利用这些食物来改变食物选择和饮食行为。正如米勒和罗尔斯所总结的那样……仅使用脂肪替代食品不应期望能在体重管理方面自发地产生改善效果。这种改善仍将依赖于长期的行为改变，这不仅包括脂肪摄入的调整，还包括总体能量摄入的调整以及能量消耗的增加。（53）尽管尚未对此进行研究，但可以推测，鼓励糖尿病患者使用含脂肪替代品的食物来实现营养管理目标需要充分的教育、持续的咨询以及个人认真的承诺和改变饮食习惯的意愿。
